{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T05:04:44Z","timestamp":1733547884112,"version":"3.30.1"},"reference-count":25,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2024.2024.0230","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T12:57:23Z","timestamp":1729774643000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of the Hemostasis and Thrombosis Unit in the Management of the Patients with Acquired Hemophilia"],"prefix":"10.4274","author":[{"given":"Antonella","family":"Mameli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Marongiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Filomena","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Schirru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Cornacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Barcellona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"PW","year":"2007","unstructured":"1. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR; UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007;109:1870-1877.","journal-title":"Blood"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2516.2002.00574.x","article-title":"Acquired anti-FVIII inhibitors in children","volume":"8","author":"RJ","year":"2002","unstructured":"2. Moraca RJ, Ragni MV. Acquired anti-FVIII inhibitors in children. Haemophilia. 2002;8:28-32.","journal-title":"Haemophilia"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: a concise review","volume":"80","author":"Franchini","year":"2005","unstructured":"3. Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55-63.","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/diagnostics13030420","article-title":"Acquired hemophilia A: an update on the etiopathogenesis, diagnosis, and treatment","volume":"13","author":"Zanon","year":"2023","unstructured":"4. Zanon E. Acquired hemophilia A: an update on the etiopathogenesis, diagnosis, and treatment. Diagnostics (Basel). 2023;13:420.","journal-title":"Diagnostics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"Baudo","year":"2012","unstructured":"5. Baudo F, Collins P, Huth-K\u00fchne A, L\u00e9vesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012;120:39-46.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Goodeve AC, Ros\u00e9n S, Verbruggen B. Haemophilia A and von Willebrand's disease. Haemophilia. 2010;16 (Suppl 5):79-84.","DOI":"10.1111\/j.1365-2516.2010.02303.x"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/medicina59101739","article-title":"Acquired hemophilia A: bleeding pattern and hemostatic therapeutic strategies","volume":"59","author":"Marino","year":"2023","unstructured":"7. Marino R. Acquired hemophilia A: bleeding pattern and hemostatic therapeutic strategies. Medicina (Kaunas). 2023;59:1739.","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/10245332.2017.1319115","article-title":"Acquired hemophilia A: a review of recent data and new therapeutic options","volume":"22","author":"Franchini","year":"2017","unstructured":"8. Franchini M, Vaglio S, Marano G, Mengoli C, Gentili S, Pupella S, Liumbruno GM. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017;22:514-520.","journal-title":"Hematology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-0032-1315757","article-title":"Acquired inhibitors of coagulation factors: Part I-Acquired hemophilia A","volume":"38","author":"Coppola","year":"2012","unstructured":"9. Coppola A, Favaloro EJ, Tufano A, Di Minno MN, Cerbone AM, Franchini M. Acquired inhibitors of coagulation factors: Part I-Acquired hemophilia A. Semin Thromb Hemost. 2012;38:433-446.","journal-title":"Semin Thromb Hemost"},{"key":"ref9","unstructured":"10. Coppola A, Franchini M, Tripodi A, Santoro RC, Castaman G, Marino R, Zanon E, Santoro C, Rivolta GF, Contino L, De Cristofaro R, Molinari AC, Gresele P, Rocino A; ad hoc Working Group (Appendix 1). Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding. Blood Transfus. 2022;20:245-262."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3324\/haematol.2008.001743","article-title":"International recommendations on the diagnosis and treatment of patients with acquired hemophilia A","volume":"94","author":"Huth-K\u00fchne","year":"2009","unstructured":"11. Huth-K\u00fchne A, Baudo F, Collins P, Ingerslev J, Kessler CM, L\u00e9vesque H, Castellano ME, Shima M, St-Louis J. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009;94:566-575.","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","unstructured":"12. Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, Di Minno G, d'Oiron R, Salaj P, Jim\u00e9nez-Yuste V, Huth-K\u00fchne A, Giangrande P. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105:1791-1801.","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl","year":"2012","unstructured":"13. Knoebl P, Marco P, Baudo F, Collins P, Huth-K\u00fchne A, Nemes L, Pellegrini F, Tengborn L, L\u00e9vesque H; EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10:622-631.","journal-title":"J Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","unstructured":"14. Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A, Virdis F, Piras MG, Lobina M, Marongiu M, Pitzalis M, Deidda F, Loizedda A, Onano S, Zoledziewska M, Sawcer S, Devoto M, Gorospe M, Abecasis GR, Floris M, Pala M, Schlessinger D, Fiorillo E, Cucca F. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036-1045.","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fimmu.2019.00035","article-title":"Ankylosing spondylitis: a trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia","volume":"10","author":"Paladini","year":"2019","unstructured":"15. Paladini F, Fiorillo MT, Tedeschi V, Cauli A, Mathieu A, Sorrentino R. Ankylosing spondylitis: a trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia. Front Immunol. 2019;10:35.","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Pardos-Gea J, Fern\u00e1ndez-D\u00edaz N, Parra R, Cortina V, Altisent C. Diagnostic delay in acquired haemophilia: analysis of causes and consequences in a 20-year Spanish cohort. Haemophilia. 2018;24:e163-e166.","DOI":"10.1111\/hae.13499"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1182\/blood-2006-04-017988","article-title":"A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study","volume":"109","author":"Astermark","year":"2007","unstructured":"17. Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, Berntorp E; FENOC Study Group. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2007;109:546-551.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Mahlangu J, Iorio A, Kenet G. Emicizumab state-of-the-art update. Haemophilia. 2022;28(Suppl 4):103-110.","DOI":"10.1111\/hae.14524"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/hae.14809","article-title":"Emicizumab for acquired haemophilia A: a case series","volume":"29","author":"Engelen","year":"2023","unstructured":"19. Engelen MM, Vandesande J, De Bent J, Van Laer C, Labarque V, Jacquemin M, Peerlinck K, Hermans C, Verhamme P, Vanassche T. Emicizumab for acquired haemophilia A: a case series. Haemophilia. 2023;29:1049-1055.","journal-title":"Haemophilia"},{"key":"ref19","unstructured":"20. Pasca S, Zanon E, Mannucci PM, Peyvandi F. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding. Blood Transfus. 2023;21:549-556."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/MBC.0000000000000370","article-title":"Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature","volume":"26","author":"Porru","year":"2015","unstructured":"21. Porru M, Mameli A, Cianchetti EM, Musu M, Montisci R, Finco G, Marongiu F. Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature. Blood Coagul Fibrinolysis. 2015;26:967-971.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.annder.2014.03.012","article-title":"Deux observations d'h\u00e9mophilie A acquise [Acquired haemophilia A: two cases]","volume":"141","author":"de Vitry","year":"2014","unstructured":"22. de Vitry A, Valois A, Weinborn M, Dupuy-de Fonclare AL, Cuny JF, Barbaud A, Schmutz JL. Deux observations d'h\u00e9mophilie A acquise [Acquired haemophilia A: two cases]. Ann Dermatol Venereol. 2014;141:441-445.","journal-title":"Ann Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Posluszny JA Jr, Napolitano LM. How do we treat life-threatening anemia in a Jehovah's Witness patient? Transfusion. 2014;54:3026-3034.","DOI":"10.1111\/trf.12888"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/imj.14773","article-title":"Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series","volume":"51","author":"Campbell","year":"2021","unstructured":"24. Campbell S, Mason J, Prasad R, Ambrose H, Hunt S, Tran H. Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series. Intern Med J. 2021;51:215-219.","journal-title":"Intern Med J"},{"key":"ref24","unstructured":"25. Zanon E, Pasca S, Borchiellini A, Lodigiani C, Molinari AC, Ambaglio C, Valeri F, Preti PS, Moscatelli P, Simioni P. Susoctocog-alfa (Obizur\u00ae) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience. Blood Transfus. 2020;18:312-321."}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:46:54Z","timestamp":1733467614000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-37336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":25,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2024.0230","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"type":"print","value":"1300-7777"},{"type":"electronic","value":"1308-5263"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}